apraclonidine has been researched along with Mydriasis in 3 studies
apraclonidine: relieves postoperative intraocular pressure following trabeculoplasty; RN given refers to parent cpd
apraclonidine : An imidazoline that is 2-amino 4,5-dihydro-1H-imidazoline in which one of the exocyclic amino hydrogens has been replaced by a 4-amino-2,6-dichlorophenyl group.
Mydriasis: Dilation of pupils to greater than 6 mm combined with failure of the pupils to constrict when stimulated with light. This condition may occur due to injury of the pupillary fibers in the oculomotor nerve, in acute angle-closure glaucoma, and in ADIE SYNDROME.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Apraclonidine testing, which is easy to perform and not distressing to the patient, identified PSD in nearly half of DM patients, the degree of mydriasis being correlated to the duration of DM and the presence of DR." | 3.73 | Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients. ( Firat, E; Kansu, T; Kavuncu, S; Koc, F, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| González Martín-Moro, J | 1 |
| Mittendrein, V | 1 |
| Pilo de la Fuente, B | 1 |
| Gutiérrez-Ortiz, C | 1 |
| Malem, A | 1 |
| Koc, F | 1 |
| Kansu, T | 1 |
| Kavuncu, S | 1 |
| Firat, E | 1 |
3 other studies available for apraclonidine and Mydriasis
| Article | Year |
|---|---|
Eponyms related to oculosympathetic paresis, the apraclonidine test and the comeback of Pourfour du Petit.
Topics: Clonidine; Eponyms; Humans; Mydriasis; Paresis | 2022 |
Unequal pupils and ptosis.
Topics: Adrenergic alpha-2 Receptor Agonists; Aged; Anisocoria; Blepharoptosis; Carotid Arteries; Clonidine; | 2017 |
Topical apraclonidine testing discloses pupillary sympathetic denervation in diabetic patients.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Clonidine; Diabetic Nephropathies; Disease Progr | 2006 |